CD73-generated adenosine promotes osteoblast differentiation

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2622-2631

  Takedachi, Masahide ^a   Oohara, Hiroyuki ^a   Smith, Brenda J ^b   Iyama, Mitsuyoshi ^a   Kobashi, Mariko ^a   Maeda, Kenichiro ^a   Long, Courtney L ^c   Humphrey, Mary B ^c   Stoecker, Barbara J ^b   Toyosawa, Satoru ^a   Thompson, Linda F ^d   Murakami, Shinya ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; BONE SIALOPROTEIN; OSTEOCALCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE DENSITY; BONE METABOLISM; CELL DIFFERENTIATION; CONTROLLED STUDY; CORTICAL BONE; GENE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPENIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRABECULAR BONE; WILD TYPE;

3T3 CELLS; 5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; CELL DIFFERENTIATION; FEMUR; GENOTYPE; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PHENOTYPE; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION; TIBIA; TIME FACTORS; TRANSFECTION; X-RAY MICROTOMOGRAPHY;

MUS;

EID: 84863393800     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23001     Document Type: Article

References (43)

1. Alatalo S, Peng Z, Janckila A, Kaija H, Vihko P, Vaananen H, Halleen J. 2003. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum. J Bone Miner Res 18:134-139.
2. Baron R, Rawadi G, Roman-Roman S. 2006. Wnt signaling: A key regulator of bone mass. Curr Top Dev Biol 76:103-127.
3. Beck GR. 2003. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 90:234-243.
4. Blackburn M, Vance C, Morschl E, Wilson C. 2009. Adenosine receptors and inflammation. Handb Exp Pharmacol 193:215-269.
5. Buckley K, Golding S, Rice J, Dillon J, Gallagher J. 2003. Release and interconversion of P2 receptor agonists by human osteoblast-like cells. FASEB J 17:1401-1410.
6. Costa M, Barbosa A, Neto E, Sá-E-Sousa A, Freitas R, Neves J, Magalhães-Cardoso T, Ferreirinha F, Correia-de-Sá P. 2010. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells. J Cell Physiol 226:1353-1366.
7. Costa MA, Barbosa A, Neto E, Sá-e-Sousa A, Freitas R, Neves JM, Magalhães-Cardoso T, Ferreirinha F, Correia-de-Sá P. 2011. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells. J Cell Physiol 226:1353-1366.
8. Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, Jacobson M, Osswald H, Thompson L, Unertl K, Eltzschig H. 2007. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115:1581-1590.
9. Eltzschig H, Ibla J, Furuta G, Leonard M, Jacobson K, Enjyoji K, Robson S, Colgan S. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198:783-796.
10. Evans B, Elford C, Pexa A, Francis K, Hughes A, Deussen A, Ham J. 2006. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. J Bone Miner Res 21:228-236.
11. Fatokun A, Stone T, Smith R. 2006. Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: The effects of glutamate and protection by purines. Bone 39:542-551.
12. Garnero P, Ferreras M, Karsdal M, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas P, Foged N, Delaissé J. 2003. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 18:859-867.
13. Grol MW, Panupinthu N, Korcok J, Sims SM, Dixon SJ. 2009. Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal 5:205-221.
14. Haskó G, Linden J, Cronstein B, Pacher P. 2008. Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7:759-770.
15. Hauschka P, Lian J, Cole D, Gundberg C. 1989. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047.
16. Hsiao E, Boudignon B, Chang W, Bencsik M, Peng J, Nguyen T, Manalac C, Halloran B, Conklin B, Nissenson R. 2008. Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc Natl Acad Sci USA 105:1209-1214.
17. Kalsi K, Lawson C, Dominguez M, Taylor P, Yacoub M, Smolenski R. 2002. Regulation of ecto-5′-nucleotidase by TNF-alpha in human endothelial cells. Mol Cell Biochem 232:113-119.
18. Kara F, Doty S, Boskey A, Goldring S, Zaidi M, Fredholm B, Cronstein B. 2010a. Adenosine A(1) receptors regulate bone resorption in mice: Adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. Arthritis Rheum 62:534-541.
19. Kara FM, Chitu V, Sloane J, Axelrod M, Fredholm BB, Stanley ER, Cronstein BN. 2010b. Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. FASEB J 24:2325-2333.
20. Katebi M, Soleimani M, Cronstein BN. 2009. Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukoc Biol 85:438-444.
21. Lennon P, Taylor C, Stahl G, Colgan S. 1998. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 188:1433-1443.
22. Nakao Y, Koike T, Ohta Y, Manaka T, Imai Y, Takaoka K. 2009. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3′, 5′-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells. Bone 44:872-877.
23. Niemelä J, Henttinen T, Yegutkin G, Airas L, Kujari A, Rajala P, Jalkanen S. 2004. IFN-alpha induced adenosine production on the endothelium: A mechanism mediated by CD73 (ecto-5′-nucleotidase) up-regulation. J Immunol 172:1646-1653.
24. Orriss IR, Burnstock G, Arnett TR. 2010. Purinergic signalling and bone remodelling. Curr Opin Pharmacol 10:322-330.
25. Piters E, Boudin E, Van Hul W. 2008. Wnt signaling: A win for bone. Arch Biochem Biophys 473:112-116.
26. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
27. Resta R, Hooker S, Laurent A, Shuck J, Misumi Y, Ikehara Y, Koretzky G, Thompson L. 1994. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73. J Immunol 153:1046-1053.
28. Romanello M, Pani B, Bicego M, D'Andrea P. 2001. Mechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun 289:1275-1281.
29. Sakamoto A, Chen M, Nakamura T, Xie T, Karsenty G, Weinstein L. 2005. Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone. J Biol Chem 280:21369-21375.
30. Shimegi S. 1998. Mitogenic action of adenosine on osteoblast-like cells, MC3T3-E1. Calcif Tissue Int 62:418-425.
31. Spychala J, Kitajewski J. 2004. Wnt and beta-catenin signaling target the expression of ecto-5′-nucleotidase and increase extracellular adenosine generation. Exp Cell Res 296:99-108.
32. Strohmeier G, Lencer W, Patapoff T, Thompson L, Carlson S, Moe S, Carnes D, Mrsny R, Madara J. 1997. Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J Clin Invest 99:2588-2601.
33. Synnestvedt K, Furuta G, Comerford K, Louis N, Karhausen J, Eltzschig H, Hansen K, Thompson L, Colgan S. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110:993-1002.
34. Takedachi M, Qu D, Ebisuno Y, Oohara H, Joachims M, McGee S, Maeda E, McEver R, Tanaka T, Miyasaka M, Murakami S, Krahn T, Blackburn M, Thompson L. 2008. CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J Immunol 180:6288-6296.
35. Thompson L, Eltzschig H, Ibla J, Van De Wiele C, Resta R, Morote-Garcia J, Colgan S. 2004. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200:1395-1405.
36. Thomson L, Ruedi J, Glass A, Moldenhauer G, Moller P, Low M, Klemens M, Massaia M, Lucas A. 1990. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 35:9-19.
37. Van De Wiele CJ, Vaughn JG, Blackburn MR, Ledent CA, Jacobson M, Jiang H, Thompson LF. 2002. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation. J Clin Invest 110:395-402.
38. Volmer J, Thompson L, Blackburn M. 2006. Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J Immunol 176:4449-4458.
39. Wan C, Gilbert S, Wang Y, Cao X, Shen X, Ramaswamy G, Jacobsen K, Alaql Z, Eberhardt A, Gerstenfeld L, Einhorn T, Deng L, Clemens T. 2008. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 105:686-691.
40. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert S, Bouxsein M, Faugere M, Guldberg R, Gerstenfeld L, Haase V, Johnson R, Schipani E, Clemens T. 2007. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616-1626.
41. Williams B, Insogna K. 2009. Where Wnts went: The exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res 24:171-178.
42. Yamashita Y, Hooker SW, Jiang H, Laurent AB, Resta R, Khare K, Coe A, Kincade PW, Thompson LF. 1998. CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur J Immunol 28:2981-2990.
43. Yegutkin G. 2008. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783:673-694.